Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages

Biochemical Journal

Volumn 356, Issue 2, 2001, Pages 515-523

  Lindholm, E M ^a   Palmer, A M ^a   Graham, A ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Atherosclerosis; Dyslipidaemia; High density lipoprotein; Lipoprotein E; Type II diabetes

Indexed keywords

PREINCUBATION CONDITION;

CHOLESTEROL; ESTERS; GLYCEROL; LIPIDS; PLASMAS; PROTEINS;

BIOCHEMISTRY;

APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LIPOPROTEIN E; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CULTURE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CULTURE MEDIUM; DYSLIPIDEMIA; HUMAN; HUMAN CELL; INCUBATION TIME; LIPID STORAGE; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; LIPOPROTEINS; MACROPHAGES; RISK FACTORS; TRIGLYCERIDES;

EID: 0035365829     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3560515     Document Type: Article

References (52)

1. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high density lipoprotein cholesterol levels: A meta-analysis of population-based prospective studies
2. Is hypertriglyceridaemia an independent risk factor for coronary heart disease?
3. The end of triglycerides in cardiovascular risk assessment?
4. The severity of coronary atherosclerosis in Type II diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles
5. Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism
6. Defects of lipoprotein metabolism in familial combined hyperlipidaemia
7. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: Cellular aspects
8. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction
9. Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM
10. Very low density lipoproteins promote triglyceride accumulation in macrophages
11. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as smaller macromolecules, including low density lipoprotein, high density lipoprotein and albumin
12. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque
13. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall - Evidence that plaque cholesterol may be derived from post-prandial lipoproteins
14. Remnant-like-particles (RLP) from NIDDM patients with apolipoprotein E3/E3 phenotype stimulated cholesteryl ester synthesis in human monocyte-derived macrophages
15. Absence of triglyceride accumulation in lipoprotein lipase-deficient human monocyte-macrophages incubated with human very low density lipoprotein
16. Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C
17. Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages
18. The familial hyperlipoproteinaemias
19. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: A correlative lipid biochemical, histochemical and electron microscopic study
20. Abnormal reverse cholesterol transport in controlled type II diabetic patients
21. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin dependent diabetes: Importance of LpA-I:A-II particles and phospholipid transfer protein
22. High density lipoprotein subfractions in non-insulin dependent diabetes mellitus and coronary artery disease
23. Insulin resistance and lipid metabolism
24. Regulation of serum-induced lipid accumulation in human monocyte-derived macrophages by interferon-γ. Correlations with apolipoprotein E production, lipoprotein lipase activity and LDL receptor-related protein expression
25. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
26. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolaemic apolipoprotein E-null mice
27. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux
28. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors
29. Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma
30. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells
31. ApoAI reduces free cholesterol accumulation in atherosclerotic lesions of apoE-deficient mice transplanted with apoE-expressing macrophages
32. Influence of macrophage-derived apoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apoprotein E-deficient mice
33. Discoidal complexes containing apolipoprotein E and their transformation by lecithin: cholesterol acyltransferase
34. Role of apolipoprotein E in hepatic lipase catalysed hydrolysis of phospholipid in high density lipoprotein
35. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
36. Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty
37. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages
38. Preparative anal quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor
39. Effects of peroxynitrite on plasma components of the reverse cholesterol transport pathway
40. Macrophage free eholesterol content regulates apolipoprotein E synthesis
41. Regulation of macrophage apolipoprotein E gene expression by cholesterol
42. Uptake of hypertriglyceridaemic very low density lipoprotein and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase and cell surface proteoglycans J
43. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins
44. Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E
45. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
46. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
47. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
48. A plasma lipoprotein containing only apolipoprotein E and with γ mobility on electrophoresis releases cholesterol from cells
49. Encapsulation of recombinant cells expressing apolipoprotein E (apoE): a gene transfer approach for hypelipidaemia
50. Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein
51. Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-α migrating high density lipoprotein particles
52. Characterization of phospholipids in pre-α HDL: selective phospholipid efflux with apolipoprotein A-I